Table 2.
Socio-demographic and clinical variables.
| Conventional ORn = 146 | LF-iMRn = 50 | p | Total | ||
|---|---|---|---|---|---|
| Gender | Female (n, %) | (57, 39) | (20, 40) | 0.892 | (77, 39.3) |
| Age (years) | Average | 54 +/− 15 | 53 +/− 15 | 0.685 | 54 +/− 15 |
| Range | 21–88 | 21–82 | 21–88 | ||
| Karnofsky pre-surgery |
Average | 84 +/− 9 | 87 +/− 8 | 0.088 | 85 +/− 9 |
| Range | 70–100 | 70–100 | 70–100 | ||
| Histopathology | LOW GRADE (n, %) | (41, 28.10) | (19, 38.00) | 0.189 | (60, 30.6) |
| Pilocytic Astrocytoma | 13, 31.7 | 4, 21.1 | 17, 28.3 | ||
| Diffuse astrocytoma | 10, 24.4 | 3, 15.8 | 13, 21.6 | ||
| Oligodendroglioma | 12, 29.3 | 10, 52.6 | 22, 36.6 | ||
| Pleomorphic Xanthoastrocytoma | 3, 7.3 | 0, 0 | 3, 5.0 | ||
| Chordoid Glioma | 1, 2.4 | 1, 5.3 | 2, 3.3 | ||
| Angiocentric glioma | 2, 4.9 | 1, 5.3 | 3, 5.0 | ||
| HIGH GRADE (n, %) | (105, 71.90) | (31, 62.00) | (136, 69.4) | ||
| Glioblastoma Multiforme | 76, 72.4 | 24, 77.4 | 100, 76.9 | ||
| Anaplastic Astrocytoma | 9, 8.6 | 1, 3.2 | 10, 7.7 | ||
| Anaplastic Oligodendroglioma | 14, 13.3 | 4, 12.9 | 18, 13.8 | ||
| Gliosarcoma | 4, 3.8 | 2, 6.5 | 6, 4.6 | ||
| Meduloblastoma | 2, 1.9 | 0, 0 | 2, 1.5 | ||
| Reintervention | Yes (n, %) | (0, 0) | (4, 8) | 0.283 | (4, 2) |
NS, No statistically significant at 5%.